<qa>  What is the name of the endpoints in the study?Reporting procedures for Adverse Events and Serious Adverse Events: Only adverse events and serious adverse events that are not considered as signs and symptoms expected and related to STEMI or NSTEMI or known side effects from the study drug will be reported in this study. Events defined as endpoints in the study e.g. all-cause death, a new myocardial infarction or stent thrombosis will not be reported as adverse events. This means that other clinical signs and symptoms, which are reported by the patient and observed by the investigator, and in the opinion of the investigator are unexpected in relation to actual diagnosis, will be reported up to 7 days post vaccination. 